Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors.

Nature chemical biology | 2011

Serine hydrolases are a diverse enzyme class representing ∼1% of all human proteins. The biological functions of most serine hydrolases remain poorly characterized owing to a lack of selective inhibitors to probe their activity in living systems. Here we show that a substantial number of serine hydrolases can be irreversibly inactivated by 1,2,3-triazole ureas, which show negligible cross-reactivity with other protein classes. Rapid lead optimization by click chemistry-enabled synthesis and competitive activity-based profiling identified 1,2,3-triazole ureas that selectively inhibit enzymes from diverse branches of the serine hydrolase class, including peptidases (acyl-peptide hydrolase, or APEH), lipases (platelet-activating factor acetylhydrolase-2, or PAFAH2) and uncharacterized hydrolases (α,β-hydrolase-11, or ABHD11), with exceptional potency in cells (sub-nanomolar) and mice (<1 mg kg(-1)). We show that APEH inhibition leads to accumulation of N-acetylated proteins and promotes proliferation in T cells. These data indicate 1,2,3-triazole ureas are a pharmacologically privileged chemotype for serine hydrolase inhibition, combining broad activity across the serine hydrolase class with tunable selectivity for individual enzymes.

Pubmed ID: 21572424 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIMH NIH HHS, United States
    Id: U54 MH084512
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA025285-03
  • Agency: NIDA NIH HHS, United States
    Id: R01 DA025285
  • Agency: NIDA NIH HHS, United States
    Id: RC2 DA028845-02
  • Agency: NCI NIH HHS, United States
    Id: CA151460
  • Agency: NCI NIH HHS, United States
    Id: R01 CA132630
  • Agency: NIDA NIH HHS, United States
    Id: RC2 DA028845
  • Agency: NIDA NIH HHS, United States
    Id: DA028845
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM090294
  • Agency: NIDA NIH HHS, United States
    Id: RC2 DA028845-01
  • Agency: NCI NIH HHS, United States
    Id: K99 CA151460
  • Agency: NCI NIH HHS, United States
    Id: K99 CA151460-01
  • Agency: NCI NIH HHS, United States
    Id: R00 CA151460
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM090294-02

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


HEK293 (tool)

RRID:CVCL_0045

Cell line HEK293 is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions